定量RT-PCR可预测干扰素耐药的慢性期CML进行imatinib治疗时的细胞遗传学反应
出处
《中华医学信息导报》
2002年第13期10-10,共1页
China Medical News
-
1Yan-jun ZHANG,Cheng-rong LU,Yan CAO,Yuan LUO,Rong-feng BAO,Shu YAN,Mei XUE,Feng ZHU,Zhe WANG,Lian-ning DUAN.Imatinib induces H2AX phosphorylation and apoptosis in chronic myelogenous leukemia cells in vitro via caspase-3/Mst1 pathway[J].Acta Pharmacologica Sinica,2012,33(4):551-557. 被引量：8
-
2Amit K.Tiwari,Hsiang-Chun Wu.Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cells[J].Chinese Journal of Cancer,2012,31(2):110-118. 被引量：4
-
3Li-xian WU,Ying WU,Rui-jia CHEN,Yang LIU,Li-sen HUANG,Li-guang LOU,Zhi-hong ZHENG,Yuan-zhong CHEN,Jian-hua XU.Curcumin derivative, C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro[J].Acta Pharmacologica Sinica,2014,35(3):401-409. 被引量：10
-
4Jacob Kjell,Lars Olson.Repositioning imatinib for spinal cord injury[J].Neural Regeneration Research,2015,10(10):1591-1593. 被引量：2
-
5Qiu-bai LI,Chao CHEN,Zhi-chao CHEN,Hong-xiang WANG,Yan-lin WU,Yong YOU,Ping ZOU.Imatinib plasma trough concentration and its correlation with characteristics and response in Chinese CML patients[J].Acta Pharmacologica Sinica,2010,31(8):999-1004. 被引量：3
-
6Jing Xie,Xiang Zhang,Bao-zhi Fang,Guang-sheng He,Yun Zhao,De-pei Wu.Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report[J].Chinese Medical Sciences Journal,2013,28(2):127-128. 被引量：1
-
7CHEN Huan LIU Kai-yan XU Lan-ping LIU Dai-hong CHEN Yu-hong SHI Hong-xia HAN Wei ZHAN Xiao-hui WANG Yu ZHAO Ting HUANG Xiao-jun.Administration of imatinib in the first 90 days after allogeneic hematopoietic cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia[J].Chinese Medical Journal,2011(2):246-252. 被引量：27
-
8夏洪平,杨惠玲.酪氨酸激酶抑制剂在肿瘤治疗中的研究进展[J].中山大学研究生学刊（自然科学与医学版）,2005,26(4):14-20. 被引量：1
-
9Jing Jiang,Mei-Shan Jin,Jian Suo,Yin-Ping Wang,Liang He,Xue-Yuan Cao.Evaluation of malignancy using Ki-67,p53,EGFR and COX-2 expressions in gastrointestinal stromal tumors[J].World Journal of Gastroenterology,2012,18(20):2569-2575. 被引量：13
-
10Tatsuo Kanda.Criminal or bystander: imatinib and second primary malignancy in GIST patients[J].Chinese Journal of Cancer Research,2013,25(5):490-492. 被引量：3
